Business / Finance

RSS

Beta-O2 receives grant from JDRF to study ßAir bio-artificial pancreas for treatment of T1D

Beta-O2 announced today that it has received a $500K grant from JDRF. The grant will be used to help fund a $1M pilot human study of Beta-O2's ßAir bio-artificial pancreas, in development as a treatment and potential cure for type 1 diabetes (T1D).

10 Sep 2014

Lucideon announces collaboration with Knight Mechanical Testing

Lucideon, an international provider of materials development, testing and assurance, and Knight Mechanical Testing, an independent mechanical testing laboratory, are pleased to announce that they have entered into a Marketing and Commercial Collaboration Agreement. The agreement means that both partners will now be to offer a complete portfolio of testing and analysis services to the orthopaedic industry.

From Lucideon 10 Sep 2014

Kinex Pharmaceuticals acquires QuaDPharma

Kinex Pharmaceuticals Inc. today announced that it has completed the acquisition of QuaDPharma, LLC., a Western New York based privately-held company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries. Financial terms of the transaction were not disclosed.

9 Sep 2014

Triple-S Salud collaborates with Voxiva and TracFone Wireless to improve health, satisfaction

Triple-S Salud has partnered with TracFone Wireless, Inc. and Voxiva, Inc. to improve the health and satisfaction of their members by providing access to free cell phones and health messaging programs.

8 Sep 2014

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company's PulseRider® in Europe, the Middle East and Africa.

8 Sep 2014

BMC receives grant from Cardinal Health Foundation to help improve effectiveness of patient care

The Cardinal Health Foundation announced it has awarded Virginia R. Litle, MD, a Thoracic Surgeon at Boston Medical Center (BMC) grant funding from the E3 Grant Program to implement best practices and help improve the effectiveness, efficiency and excellence of patient care.

8 Sep 2014

Three Clemson startup companies receive $25,000 in seed money from USAP

Clemson University Research Foundation (CURF) announced that three Clemson startup companies have each received $25,000 in seed money from the University Sponsored Application Program (USAP) offered by SC Launch.

8 Sep 2014

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, today announced it has reached an exclusive distribution agreement with Pulsar Vascular to market and promote that company’s PulseRider in Europe, the Middle East and Africa.

8 Sep 2014

TCC enters into merger with TLCC

Twinlab Consolidated Holdings, Inc. and Twinlab Consolidation Corporation announced today that they have entered into an agreement to merge in a stock-for-stock transaction with an anticipated closing date of September 15, 2014.

5 Sep 2014

LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

The Life Sciences Discovery Fund (LSDF) today announced nearly $750,000 in Proof of Concept grants to Washington state for-profit and non-profit organizations to promote translation of health-related technologies from the laboratory to the commercial marketplace.

4 Sep 2014

Pacific Edge signs agreement with SCPMG to evaluate Cxbladder User Program

Pacific Edge Ltd, a cancer diagnostics company, has signed an agreement with Southern California Permanente Medical Group (SCPMG) to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network.

3 Sep 2014

Infinity and AbbVie enter into global collaboration to develop and commercialize duvelisib

Infinity Pharmaceuticals, Inc. and AbbVie Inc. today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.

3 Sep 2014

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding the development of two new products.

3 Sep 2014

Aviv acquires assisted living and skilled nursing facilities for $83.6 million

Aviv REIT, Inc. announced today it acquired four post-acute and long-term care skilled nursing facilities ("SNF") in Washington, an assisted living facility ("ALF") in Washington and a campus in Idaho, which includes a SNF and an ALF, for a total price of $83.6 million.

2 Sep 2014

BioLegend acquires shares of Covance Antibody Services

BioLegend, Inc. (BioLegend) acquired the shares of Covance Antibody Services Inc., a business unit of Covance, located in Dedham, Massachusetts, on August 29, 2014.

From BioLegend 2 Sep 2014

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.

2 Sep 2014

BIOREM announces three new orders totalling $2.1 million

BIOREM Inc. today announced three new orders totalling $2.1 million. The orders consist of three large odour control systems for waste water treatment plants in Canada.

2 Sep 2014

USPTO issues three standard essential patents to Spherix

Spherix Incorporated -- an intellectual property development company committed to the fostering and monetization of intellectual property, today announced that the United States Patent & Trademark Office issued three patents to the Company in the month of August that are part of a standard essential family of patents.

2 Sep 2014

Pfenex reports total revenue of $3.3 million for second quarter 2014

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of high-value and difficult to manufacture proteins including biosimilar therapeutics, today provided a business update and reported financial results for the second quarter ended June 30, 2014.

30 Aug 2014

BC Technical closes acquisition of Polaris Medical Imaging

BC Technical, the nation's leading non-OEM provider of Medical Imaging Solutions, has acquired Polaris Medical Imaging, a leader in sales, service and installation of GE MRI and CT scanners.

30 Aug 2014

Business / Finance

Beta-O2 receives grant from JDRF to study ßAir bio-artificial pancreas for treatment of T1D

Lucideon announces collaboration with Knight Mechanical Testing

Kinex Pharmaceuticals acquires QuaDPharma

Triple-S Salud collaborates with Voxiva and TracFone Wireless to improve health, satisfaction

Codman reaches exclusive distribution agreement with Pulsar Vascular to market PulseRider

BMC receives grant from Cardinal Health Foundation to help improve effectiveness of patient care

Three Clemson startup companies receive $25,000 in seed money from USAP

Codman Neuro signs distribution agreement with Pulsar Vascular for PulseRider device

TCC enters into merger with TLCC

LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

Pacific Edge signs agreement with SCPMG to evaluate Cxbladder User Program

Infinity and AbbVie enter into global collaboration to develop and commercialize duvelisib

CleveXel Pharma, Guilin Pharmaceutical partner to speed up development of anti-malarial products

Aviv acquires assisted living and skilled nursing facilities for $83.6 million

BioLegend acquires shares of Covance Antibody Services

Concordia's subsidiary signs collaboration deal with Orphan Canada for PHOTOFRIN

BIOREM announces three new orders totalling $2.1 million

USPTO issues three standard essential patents to Spherix

Pfenex reports total revenue of $3.3 million for second quarter 2014

BC Technical closes acquisition of Polaris Medical Imaging

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News